Country % of IgAN Spain 24 France 33 Italy 37 Czech Republic 37 UK 39 Estonia 35 Poland 51 Sweden 30 Norway 19 Finland 40 Apart from genetic conditioning, exposure…
C-Grade I C-Grade II C-Grade III P Number of patients 401 406 248 Male/female 195:206 192:214 143:105 0.026 Age 30 31 51 <0.0001 SBP (mmHg) 120 120 136 <0.0001…
Fig. 1.1 Geographical variations in the prevalence of IgAN. Percentages represent the proportion of cases of IgAN compared to all native kidney biopsies performed. The numbers in brackets represent minority…
Fig. 6.1 The number of urinary podocytes in patients with IgAN with segmental sclerosis was higher than those in patients without (Modified from Ref. [12]) To more easily interpret the…
Fig. 15.1 Working group for the development of Clinical Guidelines for IgA Nephropathy, Progressive Renal Diseases Research by the Japanese Society of Nephrology, and Research on Intractable Disease by the…
Reference Molecule Number of patients Polymorphism Vs. normal control F/U duration (months) Renal progression Biology Lim et al. [22] Clara cell secretory protein N = 267 G38A No difference 103.8 ± 52.6 AA genotype…
Fig. 19.1 Trial profile The two groups did not differ in age, gender distribution, eGFR, urinary protein excretion, blood pressure, the proportion of patients’ given renin-angiotensin system (RAS) inhibitors, and…
Family history 1992–2000 2001–2010 With GN 95/908 (10.5 %) 77/822 (9.5 %) With dialysis 42/908 (4.6 %) 58/822 (7.1 %) Number of positive case/total number (%) Clinical phenotype of familial IgAN is generally similar…
© Springer Japan 2016Yasuhiko Tomino (ed.)Pathogenesis and Treatment in IgA Nephropathy10.1007/978-4-431-55588-9_18 18. Beyond the Differences in Tonsillectomy in IgA Nephropathy: From Rationale To Indications in Patients Yusuke Suzuki1 , Rosanna Coppo2 and Yasuhiko Tomino1 (1) Division of Nephrology,…
Fig. 8.1 Answers selected by the audience for Case 1 In January 2014, BP 124/68, proteinuria 1.5 g/day, urinary RBC 5-9/HPF, eGFR 55 mL/min/1.73 m2. Renal biopsy: acute lesion (endocapillary hypercellularity) (+), chronic…
